1. Home
  2. SAVA vs CCLD Comparison

SAVA vs CCLD Comparison

Compare SAVA & CCLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cassava Sciences Inc.

SAVA

Cassava Sciences Inc.

HOLD

Current Price

$3.27

Market Cap

156.5M

Sector

Health Care

ML Signal

HOLD

Logo CareCloud Inc.

CCLD

CareCloud Inc.

HOLD

Current Price

$3.34

Market Cap

133.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAVA
CCLD
Founded
1998
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
156.5M
133.1M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
SAVA
CCLD
Price
$3.27
$3.34
Analyst Decision
Buy
Hold
Analyst Count
2
1
Target Price
$5.00
$1.50
AVG Volume (30 Days)
1.1M
347.4K
Earning Date
11-12-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.08
Revenue
N/A
$114,315,000.00
Revenue This Year
N/A
$8.58
Revenue Next Year
N/A
$12.06
P/E Ratio
N/A
$43.79
Revenue Growth
N/A
2.97
52 Week Low
$1.15
$1.14
52 Week High
$4.98
$4.84

Technical Indicators

Market Signals
Indicator
SAVA
CCLD
Relative Strength Index (RSI) 53.65 61.52
Support Level $3.13 $3.04
Resistance Level $3.38 $3.17
Average True Range (ATR) 0.22 0.14
MACD 0.05 0.03
Stochastic Oscillator 78.62 98.08

Price Performance

Historical Comparison
SAVA
CCLD

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

About CCLD CareCloud Inc.

CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.

Share on Social Networks: